immunolog respons ivermectin treatment patient onchocerciasi effect ivermectin treatment immunolog statu individu onchocerciasi patient guatemala interv year repeat semiannu treatment ivermectin cell prolif respons onchocerc antigen month mean stimul index SI preivermectin level chang SI antigen parasit antigen signific decreas level blood eosinophil polyclon igg ige parasite-specif igg antibodi igg subclass antibodi end studi studi appar long-term safeti ivermectin absenc immunopathogen respons ivermectin treatment 